tiprankstipranks
Advertisement
Advertisement

MSLE Stock Latest News

Satellos Bioscience to Highlight Neuromuscular Pipeline at June Investor Conferences
Company AnnouncementsSatellos Bioscience to Highlight Neuromuscular Pipeline at June Investor Conferences
17d ago
6K
MSLE
Satellos resumed with a Speculative Buy at Canaccord
PremiumThe Fly
Satellos resumed with a Speculative Buy at Canaccord
23d ago
MSLE
Satellos Bioscience Sets June 17, 2026 Virtual Annual Shareholder Meeting
PremiumCompany Announcements
Satellos Bioscience Sets June 17, 2026 Virtual Annual Shareholder Meeting
24d ago
6K
MSLE
Satellos reports Q1 EPS (53c), consensus (59c)
PremiumThe Fly
Satellos reports Q1 EPS (53c), consensus (59c)
29d ago
MSLE
Satellos Bioscience Posts Wider Q1 2026 Loss but Strengthens Balance Sheet
PremiumCompany Announcements
Satellos Bioscience Posts Wider Q1 2026 Loss but Strengthens Balance Sheet
29d ago
6K
MSLE
Satellos initiated with a Buy at Guggenheim
PremiumThe FlySatellos initiated with a Buy at Guggenheim
2M ago
MSLE
Satellos Bioscience to Showcase DMD Program at April Bloom Burton Healthcare Investor Conference
Premium
Company Announcements
Satellos Bioscience to Showcase DMD Program at April Bloom Burton Healthcare Investor Conference
2M ago
6K
MSLE
Satellos management to meet with Oppenheimer
Premium
The Fly
Satellos management to meet with Oppenheimer
2M ago
MSLE
3 Best Stocks to Buy Now, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, According to Top Analysts
2M ago
FUTU
KTOS
Satellos initiated with an Outperform at Leerink
PremiumThe Fly
Satellos initiated with an Outperform at Leerink
2M ago
MSLE
Satellos has ‘catalyst-rich; 2026, says H.C. Wainwright
PremiumThe Fly
Satellos has ‘catalyst-rich; 2026, says H.C. Wainwright
3M ago
MSLE
Satellos Bioscience Posts 2025 Results, Advances SAT-3247 Into Global Phase 2 Duchenne Trials
PremiumCompany Announcements
Satellos Bioscience Posts 2025 Results, Advances SAT-3247 Into Global Phase 2 Duchenne Trials
3M ago
6K
MSLE
Cantor starts Satellos with an Overweight on DMD therapy potential
PremiumThe FlyCantor starts Satellos with an Overweight on DMD therapy potential
3M ago
MSLE
Satellos initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Satellos initiated with an Overweight at Cantor Fitzgerald
3M ago
MSLE
Satellos Bioscience Inc. Common Stock trading resumes
Premium
The Fly
Satellos Bioscience Inc. Common Stock trading resumes
3M ago
MSLE
Satellos Bioscience Inc. Common Stock trading halted, volatility trading pause
PremiumThe Fly
Satellos Bioscience Inc. Common Stock trading halted, volatility trading pause
3M ago
MSLE
Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026
PremiumCompany Announcements
Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026
3M ago
6K
MSLE
Satellos presents interim SAT-3247 data at MDA Conference
PremiumThe Fly
Satellos presents interim SAT-3247 data at MDA Conference
3M ago
MSLE
Satellos to Showcase New SAT-3247 DMD and FSHD Data at 2026 MDA Conference
PremiumCompany Announcements
Satellos to Showcase New SAT-3247 DMD and FSHD Data at 2026 MDA Conference
4M ago
6K
MSLE
Satellos Bioscience to Court Investors as Phase 2 DMD Program Advances
PremiumCompany AnnouncementsSatellos Bioscience to Court Investors as Phase 2 DMD Program Advances
4M ago
6K
MSLE
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy
Premium
Company Announcements
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy
4M ago
6K
MSLE
Satellos to Highlight Duchenne Drug Program at Series of Investor Conferences
Premium
Company Announcements
Satellos to Highlight Duchenne Drug Program at Series of Investor Conferences
4M ago
MSLE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >